AlphaValue Corporate Services
This research has been commissioned and paid for by the company and does therefore not constitute an inducement caught by the prohibition under MiFID II

Chargeurs

CR
Bloomberg   CRI FP
Support Services  /  France  Web Site   |   Investors Relation
From an industrialist to a luxury player
Pros
  • Chargeurs is focusing on no-nonsense profitable growth, with a keen eye for developing businesses in niche markets with a low capital intensity
  • The creation of Museum Studios, a unique one-stop-shop offering in a very scattered market, demonstrates Chargeurs' ingenuity and this has rapidly established itself as the group's new growth lever
  • The rapid expansion of Chargeurs' Luxury division presents several opportunities, culminating in a significant forthcoming acquisition
Cons
  • The firm is small in absolute terms and may fall below most investors' radars
  • The uncertain macro-economic environment is weighing on the group's largest division, Chargeurs Advanced Materials, even if volume has reached an inflection point
  • Chargeurs' net debt is now high (3.5x leverage) and may deteriorate further following an acquisition
Updates
21/06/24OpinionBuy vs Add
30/04/24 EarningsQ1-24 Chargeurs kicks off the year in hig...
16/02/24 EarningsOperational results in line with the 2023 e...
20/12/23 M&A /Corp.Chargeurs, the rationale behind a takeov...
15/11/23 EPSWe have downgraded our EPS estimates...
15/11/23 NAVGiven that we have based our NAV valua...
15/11/23 DCFThe sharp fall in our DCF comes from the...
13/11/23 EarningsThe worst is over as Chargeurs Advance...
16/09/23 EPSWe have revised our estimates for 2023 ...
16/09/23 NAVGiven that we have based our NAV estim...
16/09/23 DCFThe sharp fall in our DCF comes from our...
12/09/23 EarningsSolace in museums
26/05/23 EPSWe have revised our FY 23-24 assumptio...
26/05/23 NAVOur NAV has increased on the back of u...
26/05/23 DCFOur DCF-based valuation is reduced slig...
25/05/23 EarningsHeading for a Chargeurs Advanced Mate...
13/03/23 EarningsStrong 2022 introduces a promising 2023
19/12/22 StrategyFrom an industrialist to a luxury player?
15/11/22 EPSWe have incorporated the 9m 22 number...
15/11/22 DCFIn line with the downward revision of our ...
10/11/22 EarningsQ3 22: a subdued quarter
22/09/22 EPSFollowing the publication of the H1 22 res...
22/09/22 DCFOur DCF-based valuation sees a margina...
15/09/22 Other newsThe up-and-coming luxury player
12/09/22 EarningsH1 22: an encouraging start to FY 2022 d...
13/05/22 EarningsUpbeat start to 2022 propelled by strong ...
24/03/22 EPSWe have incorporated the FY21 figures, ...
24/03/22 NAVWe have adjusted the value of the differe...
24/03/22 DCFOur DCF-based valuation sees a margina...
18/02/22 EarningsFY21: CPF achieves record year, group’s...
11/11/21 EarningsQ3 performance confirms our FY view
23/09/21 LatestChange of valuation profile
13/09/21 EarningsH1 21: strong execution and record order...
05/05/21 TargetThe adjustments made to our FY21-22 E...
05/05/21 EPSFollowing the publication of the record Q...
05/05/21 EarningsProtective Films and Healthcare Solution...
29/04/21 TargetThe valuation increases across the differ...
29/04/21 EPSThe significant upgrade in our FY21-22 E...
29/04/21 NAVWe have updated our estimated NAV by i...
29/04/21 DCFThe rise in our DCF-based valuation is dri...
20/04/21 EPSWe have revised our earnings expectatio...
20/04/21 NAVThe valuation of Chargeurs' business line...
24/02/21 EarningsCHS leads FY20 record result as Charge...
28/01/21 EPSWe have raised our EPS estimates for F...
28/01/21 EarningsFY20 ends on a high note as Protective F...
11/11/20 EarningsHealthcare-led Q3 lifts full-year outlook
11/11/20 EPSOur FY20 EPS estimate increases on the...
14/09/20 TargetOur target price is virtually unchanged foll...
14/09/20 EPSOur FY20 EPS estimate sees a major up...
14/09/20 NAVOur NAV/SOTP valuation is mainly impac...
Target
Upside 34.5%
Price (€) 10.4
Market Cap (€M) 259
Perf. 1W: -10.3%
Perf. 1M: -20.5%
Perf. 3M: -12.9%
Perf Ytd: -11.0%
10 day relative perf. to stoxx600: -18.5%
20 day relative perf. to stoxx600: -19.9%